Glaxo has doubts that its Alli weight loss products are being tempered. Actually GlaxoSmithKline (GSK) Consumer Healthcare has received complaints about its Alli weight loss products from seven...
GlaxoSmithKline (GSK) Consumer Healthcare has received complaints about its Alli weight loss products from seven states. That is why, GSK has announced yesterday that it is "voluntarily recalling all...
Looking backward to improve its future, Pfizer will once again try to gain FDA approval to market its blockbuster drug, atorvastatin (Lipitor), over-the-counter (OTC). Peter Loftus reports in...
A few years ago a novel antiplatelet agent from Merck seemed all but dead. Vorapaxar, a thrombin receptor antagonist, was widely thought to have no future after unacceptably high serious bleeding...